151 related articles for article (PubMed ID: 17324924)
1. Mammalian tumor suppressor Int6 specifically targets hypoxia inducible factor 2 alpha for degradation by hypoxia- and pVHL-independent regulation.
Chen L; Uchida K; Endler A; Shibasaki F
J Biol Chem; 2007 Apr; 282(17):12707-16. PubMed ID: 17324924
[TBL] [Abstract][Full Text] [Related]
2. Int6/eIF3e silencing promotes functional blood vessel outgrowth and enhances wound healing by upregulating hypoxia-induced factor 2alpha expression.
Chen L; Endler A; Uchida K; Horiguchi S; Morizane Y; Iijima O; Toi M; Shibasaki F
Circulation; 2010 Aug; 122(9):910-9. PubMed ID: 20713899
[TBL] [Abstract][Full Text] [Related]
3. Int6 silencing causes induction of angiogenic factors in neuronal cells via accumulation of hypoxia-inducible factor 2α and decreases brain damage in rats.
Miyashita R; Chen L; Oshiro H; Uchino H; Shibasaki F
Neurosci Lett; 2012 Oct; 528(1):83-8. PubMed ID: 22960363
[TBL] [Abstract][Full Text] [Related]
4. Kelch-like 20 up-regulates the expression of hypoxia-inducible factor-2α through hypoxia- and von Hippel-Lindau tumor suppressor protein-independent regulatory mechanisms.
Higashimura Y; Terai T; Yamaji R; Mitani T; Ogawa M; Harada N; Inui H; Nakano Y
Biochem Biophys Res Commun; 2011 Sep; 413(2):201-5. PubMed ID: 21888897
[TBL] [Abstract][Full Text] [Related]
5. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
Okumura F; Uematsu K; Byrne SD; Hirano M; Joo-Okumura A; Nishikimi A; Shuin T; Fukui Y; Nakatsukasa K; Kamura T
Mol Cell Biol; 2016 Jun; 36(12):1803-17. PubMed ID: 27090638
[TBL] [Abstract][Full Text] [Related]
6. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor as an angiogenic master switch.
Hashimoto T; Shibasaki F
Front Pediatr; 2015; 3():33. PubMed ID: 25964891
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-2α stabilizes the von Hippel-Lindau (VHL) disease suppressor, Myb-related protein 2.
Okumura F; Joo-Okumura A; Nakatsukasa K; Kamura T
PLoS One; 2017; 12(4):e0175593. PubMed ID: 28394947
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
Cockman ME; Masson N; Mole DR; Jaakkola P; Chang GW; Clifford SC; Maher ER; Pugh CW; Ratcliffe PJ; Maxwell PH
J Biol Chem; 2000 Aug; 275(33):25733-41. PubMed ID: 10823831
[TBL] [Abstract][Full Text] [Related]
10. Int6/eIF3e silenced HIF2α stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling.
Endler A; Chen L; Li Q; Uchida K; Hashimoto T; Lu L; Xu GT; Shibasaki F
Cytokine; 2013 Apr; 62(1):115-22. PubMed ID: 23478175
[TBL] [Abstract][Full Text] [Related]
11. pVHL-mediated degradation of HIF-2α regulates estrogen receptor α expression in normoxic breast cancer cells.
Higashimura Y; Kitakaze T; Harada N; Inui H; Nakano Y; Yamaji R
FEBS Lett; 2016 Aug; 590(16):2690-9. PubMed ID: 27323688
[TBL] [Abstract][Full Text] [Related]
12. The Bad, the Good and eIF3e/INT6.
Sesen J; Casaos J; Scotland SJ; Seva C; Eisinger-Mathason TS; Skuli N
Front Biosci (Landmark Ed); 2017 Jan; 22(1):1-20. PubMed ID: 27814599
[TBL] [Abstract][Full Text] [Related]
13. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex.
Miller F; Kentsis A; Osman R; Pan ZQ
J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064
[TBL] [Abstract][Full Text] [Related]
15. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
17. Identification of residues critical for regulation of protein stability and the transactivation function of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor gene product.
Pereira T; Zheng X; Ruas JL; Tanimoto K; Poellinger L
J Biol Chem; 2003 Feb; 278(9):6816-23. PubMed ID: 12468553
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.
Zimmer M; Doucette D; Siddiqui N; Iliopoulos O
Mol Cancer Res; 2004 Feb; 2(2):89-95. PubMed ID: 14985465
[TBL] [Abstract][Full Text] [Related]
19. Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease.
Okamoto N; Tanaka A; Jung K; Karasawa K; Orito K; Matsuda A; Amagai Y; Oida K; Ohmori K; Matsuda H
Cardiovasc Res; 2011 Nov; 92(2):209-17. PubMed ID: 21771896
[TBL] [Abstract][Full Text] [Related]
20. Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein.
Kong X; Alvarez-Castelao B; Lin Z; Castaño JG; Caro J
J Biol Chem; 2007 May; 282(21):15498-505. PubMed ID: 17403672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
